Skip navigation
  • Sciety Labs 🧪 (Experimental)
  • Search
Sciety application utilities

Immunology

  • Subscribe to feed (RSS)

Showing page 83 of 175 pages of list content

  • IL4I1 binds to TMPRSS13 and competes with SARS-Cov2 Spike

    This article's authors
    1. Jérôme Gatineau
    2. Charlotte Nidercorne
    3. Aurélie Dupont
    4. Marie-Line Puiffe
    5. José L Cohen
    6. Valérie Molinier-Frenkel
    7. Florence Niedergang
    8. Flavia Castellano
    This article has 1 evaluations Latest evaluation on Dec 30, 2021 Published on Dec 25, 2021
  • Broad and Long-lasting Immune Response against SARS-CoV-2 Omicron and Other Variants by PIKA-Adjuvanted Recombinant SARS-CoV-2 Spike (S) Protein Subunit Vaccine (YS-SC2-010)

    This article's authors
    1. Yuan Liu
    2. Nan Zhang
    3. Bin Wang
    4. Yi Zhang
    This article has 1 evaluations Latest evaluation on Dec 30, 2021 Published on Dec 23, 2021
  • Two doses of mRNA vaccine elicit cross-neutralizing memory B-cells against SARS-CoV-2 Omicron variant

    This article's authors
    1. Ryutaro Kotaki
    2. Yu Adachi
    3. Saya Moriyama
    4. Taishi Onodera
    5. Shuetsu Fukushi
    6. Takaki Nagakura
    7. Keisuke Tonouchi
    8. Kazutaka Terahara
    9. Lin Sun
    10. Tomohiro Takano
    11. Ayae Nishiyama
    12. Masaharu Shinkai
    13. Kunihiro Oba
    14. Fukumi Nakamura-Uchiyama
    15. Hidefumi Shimizu
    16. Tadaki Suzuki
    17. Takayuki Matsumura
    18. Masanori Isogawa
    19. Yoshimasa Takahashi
    This article has 1 evaluations Latest evaluation on Dec 30, 2021 Published on Dec 26, 2021
  • Waning immune responses against SARS-CoV-2 among vaccinees in Hong Kong

    This article's authors
    1. Qiaoli Peng
    2. Runhong Zhou
    3. Yuewen Wang
    4. Meiqing Zhao
    5. Na Liu
    6. Shuang Li
    7. Haode Huang
    8. Dawei Yang
    9. Ka-Kit Au
    10. Hui Wang
    11. Kwan Man
    12. Kwok-Yung Yuen
    13. Zhiwei Chen
    This article has 1 evaluations Latest evaluation on Dec 30, 2021 Published on Dec 23, 2021
  • Interferon-induced transmembrane protein 3 (IFITM3) limits lethality of SARS-CoV-2 in mice

    This article's authors
    1. Ashley Zani
    2. Adam D. Kenney
    3. Jeffrey Kawahara
    4. Adrian C. Eddy
    5. Xiao-Liang Wang
    6. Mahesh KC
    7. Mijia Lu
    8. Emily A. Hemann
    9. Jianrong Li
    10. Mark E. Peeples
    11. Luanne Hall-Stoodley
    12. Adriana Forero
    13. Chuanxi Cai
    14. Jianjie Ma
    15. Jacob S. Yount
    This article has 1 evaluations Latest evaluation on Dec 30, 2021 Published on Dec 23, 2021
  • Structural basis for antibody resistance to SARS-CoV-2 omicron variant

    This article's authors
    1. Gabriele Cerutti
    2. Yicheng Guo
    3. Lihong Liu
    4. Zhening Zhang
    5. Liyuan Liu
    6. Yang Luo
    7. Yiming Huang
    8. Harris H. Wang
    9. David D. Ho
    10. Zizhang Sheng
    11. Lawrence Shapiro
    This article has 1 evaluations Latest evaluation on Dec 27, 2021 Published on Dec 23, 2021
  • Anti-SARS-CoV-2 human antibodies retaining neutralizing activity against SARS-CoV-2 B.1.1.529 (omicron)

    This article's authors
    1. Maya Imbrechts
    2. Winnie Kerstens
    3. Madina Rasulova
    4. Thomas Vercruysse
    5. Wim Maes
    6. Louanne Ampofo
    7. Karen Ven
    8. Jeroen Lammertyn
    9. Karen Vanhoorelbeke
    10. Nico Callewaert
    11. Johan Neyts
    12. Kai Dallmeier
    13. Paul Declerck
    14. Hendrik Jan Thibaut
    15. Nick Geukens
    This article has 1 evaluations Latest evaluation on Dec 27, 2021 Published on Dec 23, 2021
  • Virus-like particles (VLPs) are efficient tools for boosting mRNA-induced antibodies

    This article's authors
    1. Anne-Cathrine S. Vogt
    2. Lukas Jörg
    3. Byron Martina
    4. Pascal S. Krenger
    5. Xinyue Chang
    6. Andris Zeltins
    7. Monique Vogel
    8. Mona O. Mohsen
    9. Martin F. Bachmann
    This article has 1 evaluations Latest evaluation on Dec 24, 2021 Published on Dec 22, 2021
  • Longitudinal characterisation of phagocytic and neutralisation functions of anti-Spike antibodies in plasma of patients after SARS-CoV-2 infection

    This article's authors
    1. Anurag Adhikari
    2. Arunasingam Abayasingam
    3. Chaturaka Rodrigo
    4. David Agapiou
    5. Elvis Pandzic
    6. Nicholas A Brasher
    7. Bentotage Samitha Madushan Fernando
    8. Elizabeth Keoshkerian
    9. Hui Li
    10. Ha Na Kim
    11. Megan Lord
    12. Gordona Popovic
    13. William Rawlinson
    14. Michael Mina
    15. Jeffrey J Post
    16. Bernard Hudson
    17. Nicole Gilroy
    18. Adam W. Bartlett
    19. Golo Ahlenstiel
    20. Branka Grubor-Bauk
    21. Dominic Dwyer
    22. Pamela Konecny
    23. Andrew R Lloyd
    24. Marianne Martinello
    25. Rowena A Bull
    26. Nicodemus Tedla
    This article has 1 evaluations Latest evaluation on Dec 24, 2021 Published on Dec 22, 2021
  • mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variant

    This article's authors
    1. Venkata-Viswanadh Edara
    2. Kelly E. Manning
    3. Madison Ellis
    4. Lilin Lai
    5. Kathryn M. Moore
    6. Stephanie L. Foster
    7. Katharine Floyd
    8. Meredith E. Davis-Gardner
    9. Grace Mantus
    10. Lindsay E. Nyhoff
    11. Sarah Bechnak
    12. Ghina Alaaeddine
    13. Amal Naji
    14. Hady Samaha
    15. Matthew Lee
    16. Laurel Bristow
    17. Laila Hussaini
    18. Caroline Rose Ciric
    19. Phuong-Vi Nguyen
    20. Matthew Gagne
    21. Jesmine Roberts-Torres
    22. Amy R. Henry
    23. Sucheta Godbole
    24. Arash Grakoui
    25. Marybeth Sexton
    26. Anne Piantadosi
    27. Jesse J. Waggoner
    28. Daniel C. Douek
    29. Evan J. Anderson
    30. Nadine Rouphael
    31. Jens Wrammert
    32. Mehul S. Suthar
    This article has 1 evaluations Latest evaluation on Dec 24, 2021 Published on Dec 22, 2021
Previous Next
Stay updated. Get involved.
Subscribe to Mailing List
  • Blog
  • About Sciety
  • Contact
  • Follow us on Twitter
  • Follow us on Facebook
© 2022 eLife Sciences Publications Ltd. Legal information